Literature DB >> 32889384

Recent advances in the development of ligands specifically targeting telomeric multimeric G-quadruplexes.

Jingfang Zhao1, Qianqian Zhai2.   

Abstract

Long human telomeric DNA sequence could form higher-order G-quadruplex structures, namely telomeric multimeric G-quadruplexes. The formation of telomeric multimeric G-quadruplexes has been demonstrated. Several efforts have been devoted to the development of ligands targeting telomeric multimeric G-quadruplexes in recent years. The reported ligands specifically targeting telomeric multimeric G-quadruplexes exhibited either high anticancer activity with effective stabilization ability or distinct fluorescence responses to telomeric multimeric G-quadruplexes. In this review, the ligands including three types of small molecules are discussed which focus on their structural features and binding modes. Furthermore, we put forward the promising prospects and current challenges. This presented review might provide new strategies to exploit more sophisticated ligands targeting telomeric multimeric G-quadruplexes.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Binding modes; Ligands; Recognition specificity; Telomeric multimeric G-quadruplexes

Year:  2020        PMID: 32889384     DOI: 10.1016/j.bioorg.2020.104229

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  3 in total

Review 1.  Nucleic Acid Aptamers in Nanotechnology.

Authors:  Valentina V Sinitsyna; Alexandre A Vetcher
Journal:  Biomedicines       Date:  2022-05-06

2.  G-quadruplex binding properties of a potent PARP-1 inhibitor derived from 7-azaindole-1-carboxamide.

Authors:  Sabrina Dallavalle; Loana Musso; Roberto Artali; Anna Aviñó; Leonardo Scaglioni; Ramon Eritja; Raimundo Gargallo; Stefania Mazzini
Journal:  Sci Rep       Date:  2021-02-16       Impact factor: 4.379

Review 3.  Major Achievements in the Design of Quadruplex-Interactive Small Molecules.

Authors:  Eduarda Mendes; Israa M Aljnadi; Bárbara Bahls; Bruno L Victor; Alexandra Paulo
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.